Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
SAMDAILY.US - ISSUE OF AUGUST 02, 2020 SAM #6821
SOLICITATION NOTICE

65 -- Department of Defense Pharmacy Uniform Formulary Blanket Purchase Agreement / Uniform Formulary Additional Discount Program

Notice Date
7/31/2020 9:24:47 AM
 
Notice Type
Solicitation
 
NAICS
325412 — Pharmaceutical Preparation Manufacturing
 
Contracting Office
DEFENSE HEALTH AGENCY - AURORA AURORA CO 80011 USA
 
ZIP Code
80011
 
Solicitation Number
HT9402-20-Q-0005
 
Response Due
9/18/2020 10:00:00 AM
 
Archive Date
12/31/2020
 
Point of Contact
Yvette Dluhos
 
E-Mail Address
yvette.h.dluhos.civ@mail.mil
(yvette.h.dluhos.civ@mail.mil)
 
Description
Background: The Department of Defense (DoD) is required by law (10 U.S.C. � 1074g) to establish an effective, efficient, integrated pharmacy benefits program for the Military Health System (MHS) which includes the purchase pharmaceutical agents. The law and implementing regulation (32 CFR Section 199.21) describe the process by which the DoD Pharmacy and Therapeutics (P&T) Committee will consider the relative clinical effectiveness and relative cost effectiveness of pharmaceutical agents in a therapeutic class in recommending the selection of agents for the DoD Uniform Formulary (UF) and, for cost sharing purposes, the classification of a pharmaceutical agent as generic, formulary, Basic Core Formulary (BCF), Extended Core Formulary (ECF), or non-formulary (NF). Prior to the scheduled P&T Committee meeting, a Request for Quotation (RFQ) for pharmaceutical agents within Drug Classes identified for placement on the UF has been issued to obtain quotes from industry. The Defense Health Agency may award Uniform Formulary Blanket Purchase Agreements (UF BPA) and the Uniform Formulary Additional Discount Program Agreements (UF ADP) based on the UF decision. This process is described in the attached RFQ. P&T COMMITTEE MEETING: November 2020: The following drug classes/subclasses and agents will be reviewed: ADHD Agents, SUB CLASS: Stimulants Respiratory Interleukins, SUB CLASS: NA RFQ: The RFQ, including UF BPA and UF ADP appendices are attached herein. The historical utilization data including quantity dispensed and 30 day equivalents by mouth is also attached herein. Pre-Proposal Teleconference: See Paragraphs 2.4 and 2.5 of the RFQ. The pre-proposal teleconference agenda with dial-in information will be sent out via email after manufacturer R.S.V.P. with the RFQ point of contact. RFQ point of contact: See Part 2.3 of the RFQ. For additional information, search DoD Pharmacy and Therapeutics (P&T) Committee at http://www.health.mil/POD
 
Web Link
SAM.gov Permalink
(https://beta.sam.gov/opp/04e8eaba5092485e8208ad1199f0f8c3/view)
 
Place of Performance
Address: San Antonio, TX 78230, USA
Zip Code: 78230
Country: USA
 
Record
SN05741963-F 20200802/200731230148 (samdaily.us)
 
Source
SAM.gov Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's SAM Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.